Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

Kerstin Wennhold, PhD, Martin Thelen, Maria gracia Marquez, Christof Scheid, MD PhD, Alexander Shimabukuro-Vornhagen, MD, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 1030.

https://doi.org/10.1182/blood.V126.23.1030.1030

Published: 2015

Journal Articles

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

Alexander Shimabukuro-Vornhagen, MD, María Alejandra García-Márquez, PhD, Rieke N. Fischer, Juliane Iltgen-Breburda, Anne Fiedler, Kerstin Wennhold, PhD, Gunter Rappl, Hinrich Abken, Pia Hartmann, Clara Lehmann, Thomas Koslowsky, Marco Herling, MD, Dirk Beutner, Dominik Wolf, MD, Gerd Fätkenheuer, Andrea Rubbert-Roth, Michael Hallek, MD, Sebastian Theurich, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 3432.

https://doi.org/10.1182/blood.V126.23.3432.3432

Published: 2015

Journal Articles

In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy

Kerstin Wennhold, Nela Klein-Gonzalez, PhD, Michael von Bergwelt-Baildon, MD PhD, Alexander Shimabukuro-Vornhagen, MD

Blood (2014) 124 (21): 2740.

https://doi.org/10.1182/blood.V124.21.2740.2740

Published: 2014

Journal Articles

Changes in the T and B- Cell Subsets Following Treatment with a CD25-Antibody in Patients with Steroid Refractory GvHD

Geothy Chakupurakal, MBBS, MRCPath, PhD, Maria Garcia- Marquez, Alexander Shimabukuro- Vornhagen, MD, Hans Anton Schloesser, MD, Udo Holtick, MDPhD, Christoph Scheid, MD PhD, Michael von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 2497.

https://doi.org/10.1182/blood.V124.21.2497.2497

Published: 2014

Journal Articles

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Alexander Shimabukuro-Vornhagen, MD, María García Márquez, Rieke Fischer, MD, Kerstin Wennhold, Juliane Iltgen, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 1425.

https://doi.org/10.1182/blood.V124.21.1425.1425

Published: 2014

Journal Articles

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

Udo Holtick, MDPhD, Alexander Shimabukuro-Vornhagen, MD, Geothy Chakupurakal, MBBS, MRCPath, PhD, Sebastian Theurich, MD, Silke Leitzke, Dominik Wolf, MD, Michael Hallek, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christof Scheid, MDPhD, Jens Chemnitz, MD

Blood (2014) 124 (21): 3904.

https://doi.org/10.1182/blood.V124.21.3904.3904

Published: 2014

Journal Articles

Complex interactions between B cells and dendritic cells

María García-Marquez, Alexander Shimabukuro-Vornhagen, Michael von Bergwelt-Baildon

Blood (2013) 121 (12): 2367–2368.

https://doi.org/10.1182/blood-2012-12-468017

Published: 2013

Journal Articles

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Sebastian Theurich, MD, Joke Malcher, Kerstin Wennhold, Alexander Shimabukuro-Vornhagen, MD, Jens M. Chemnitz, MD, Holtick Udo, MD, Anke Krause, MD, Carsten Kobe, MD, Deniz Kahraman, MD, Chakupurakal Geothy, Andreas Engert, MD PhD, Scheid Christof, MD, Michael Hallek, MD PhD, Michael von Bergwelt-Baildon, MD, PhD

Blood (2012) 120 (21): 4213.

https://doi.org/10.1182/blood.V120.21.4213.4213

Published: 2012

Journal Articles

Activated primary human B cells efficiently induce early CD40L and CD107a expression in CD4 + T cells

Sebastian Theurich, Joke Malcher, Hans J. Becker, Jens M. Chemnitz, Tanja M. Liebig, Alexander Shimabukuro-Vornhagen, Michael von Bergwelt-Baildon

Blood (2011) 118 (22): 5979–5980.

https://doi.org/10.1182/blood-2011-05-356683

Published: 2011

Journal Articles

Response: Friend or foe in GVHD: a matter of targeting the right B-cell subset

Alexander Shimabukuro-Vornhagen, Michael S. von Bergwelt-Baildon

Blood (2010) 115 (12): 2559–2560.

https://doi.org/10.1182/blood-2009-12-254821

Published: 2010

Journal Articles

The role of B cells in the pathogenesis of graft-versus-host disease

Alexander Shimabukuro-Vornhagen, Michael J. Hallek, Rainer F. Storb, Michael S. von Bergwelt-Baildon

Blood (2009) 114 (24): 4919–4927.

https://doi.org/10.1182/blood-2008-10-161638

Published: 2009

Journal Articles

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

Alexander Shimabukuro-Vornhagen, Eisei Kondo, Tanja Liebig, Michael von Bergwelt-Baildon

Blood (2009) 114 (3): 746–747.

https://doi.org/10.1182/blood-2009-03-212886

Published: 2009

Journal Articles

Statins Inhibit the Function of Human Antigen-Presenting Cells

Alexander Shimabukuro-Vornhagen, MD, Tanja Liebig, Shahram Zoghi, Clemens M Wendtner, MD, Michael S von Bergwelt-Baildon, MD

Blood (2008) 112 (11): 2560.

https://doi.org/10.1182/blood.V112.11.2560.2560

Published: 2008

Journal Articles

Statins inhibit human APC function: implications for the treatment of GVHD

Alexander Shimabukuro-Vornhagen, Tanja Liebig, Michael von Bergwelt-Baildon

Blood (2008) 112 (4): 1544–1545.

https://doi.org/10.1182/blood-2008-04-149609

Published: 2008

Journal Articles

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

Michael von Bergwelt-Baildon, Alexander Shimabukuro-Vornhagen, Alexey Popov, Nela Klein-Gonzalez, Francesca Fiore, Svenja Debey, Andreas Draube, Britta Maecker, Isaura Menezes, Lee M. Nadler, Joachim L. Schultze

Blood (2006) 107 (7): 2786–2789.

https://doi.org/10.1182/blood-2004-01-0113

Published: 2006

Includes: Supplemental data

NARROW

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy

Changes in the T and B- Cell Subsets Following Treatment with a CD25-Antibody in Patients with Steroid Refractory GvHD

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

Complex interactions between B cells and dendritic cells

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Activated primary human B cells efficiently induce early CD40L and CD107a expression in CD4 + T cells

Response: Friend or foe in GVHD: a matter of targeting the right B-cell subset

The role of B cells in the pathogenesis of graft-versus-host disease

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

Statins Inhibit the Function of Human Antigen-Presenting Cells

Statins inhibit human APC function: implications for the treatment of GVHD

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only